TLR4 and schizophrenia: Our study reveals that LY96 expression is significantly elevated in schizophrenia patients compared to control samples, thereby supporting the involvement of LY96 in LPS-induced TLR4 signaling pathway activation and the pathogenesis of schizophrenia.